577 related articles for article (PubMed ID: 27190276)
1. Intermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.
Manukhina EB; Downey HF; Shi X; Mallet RT
Exp Biol Med (Maywood); 2016 Jun; 241(12):1351-63. PubMed ID: 27190276
[TBL] [Abstract][Full Text] [Related]
2. Cerebral hypoperfusion and glucose hypometabolism: Key pathophysiological modulators promote neurodegeneration, cognitive impairment, and Alzheimer's disease.
Daulatzai MA
J Neurosci Res; 2017 Apr; 95(4):943-972. PubMed ID: 27350397
[TBL] [Abstract][Full Text] [Related]
3. Alzheimer's disease in late-life dementia: a minor toxic consequence of devastating cerebrovascular dysfunction.
Henry-Feugeas MC
Med Hypotheses; 2008; 70(4):866-75. PubMed ID: 17825499
[TBL] [Abstract][Full Text] [Related]
4. Intermittent hypoxia training effectively protects against cognitive decline caused by acute hypoxia exposure.
Zhang G; Yang G; Zhou Y; Cao Z; Yin M; Ma L; Fan M; Zhao YQ; Zhu L
Pflugers Arch; 2024 Feb; 476(2):197-210. PubMed ID: 37994929
[TBL] [Abstract][Full Text] [Related]
5. Intermittent Hypoxia Training Prevents Deficient Learning-Memory Behavior in Mice Modeling Alzheimer's Disease: A Pilot Study.
Ryou MG; Chen X; Cai M; Wang H; Jung ME; Metzger DB; Mallet RT; Shi X
Front Aging Neurosci; 2021; 13():674688. PubMed ID: 34276338
[TBL] [Abstract][Full Text] [Related]
6. Targeting thrombin: an inflammatory neurotoxin in Alzheimer's disease.
Grammas P; Martinez JM
J Alzheimers Dis; 2014; 42 Suppl 4():S537-44. PubMed ID: 25079808
[TBL] [Abstract][Full Text] [Related]
7. Capillary dysfunction is associated with symptom severity and neurodegeneration in Alzheimer's disease.
Nielsen RB; Egefjord L; Angleys H; Mouridsen K; Gejl M; Møller A; Brock B; Brændgaard H; Gottrup H; Rungby J; Eskildsen SF; Østergaard L
Alzheimers Dement; 2017 Oct; 13(10):1143-1153. PubMed ID: 28343848
[TBL] [Abstract][Full Text] [Related]
8. Alzheimer's disease, cerebrovascular dysfunction and the benefits of exercise: from vessels to neurons.
Lange-Asschenfeldt C; Kojda G
Exp Gerontol; 2008 Jun; 43(6):499-504. PubMed ID: 18474414
[TBL] [Abstract][Full Text] [Related]
9. The effects of impaired cerebral circulation on Alzheimer's disease pathology: evidence from animal studies.
Villarreal AE; Barron R; Rao KS; Britton GB
J Alzheimers Dis; 2014; 42(3):707-22. PubMed ID: 24927711
[TBL] [Abstract][Full Text] [Related]
10. Alzheimer disease and cerebrovascular pathology: an update.
Jellinger KA
J Neural Transm (Vienna); 2002 May; 109(5-6):813-36. PubMed ID: 12111471
[TBL] [Abstract][Full Text] [Related]
11. Vascular risk factors: a ticking time bomb to Alzheimer's disease.
de la Torre JC
Am J Alzheimers Dis Other Demen; 2013 Sep; 28(6):551-9. PubMed ID: 23813612
[TBL] [Abstract][Full Text] [Related]
12. Aberrant expression of nitric oxide synthase III in Alzheimer's disease: relevance to cerebral vasculopathy and neurodegeneration.
de la Monte SM; Lu BX; Sohn YK; Etienne D; Kraft J; Ganju N; Wands JR
Neurobiol Aging; 2000; 21(2):309-19. PubMed ID: 10867216
[TBL] [Abstract][Full Text] [Related]
13. Oxidative stress and cerebrovascular dysfunction in mouse models of Alzheimer's disease.
Hamel E; Nicolakakis N; Aboulkassim T; Ongali B; Tong XK
Exp Physiol; 2008 Jan; 93(1):116-20. PubMed ID: 17911359
[TBL] [Abstract][Full Text] [Related]
14. Cerebral hemodynamics and vascular risk factors: setting the stage for Alzheimer's disease.
de la Torre JC
J Alzheimers Dis; 2012; 32(3):553-67. PubMed ID: 22842871
[TBL] [Abstract][Full Text] [Related]
15. Vascular factors in Alzheimer's disease.
Kalaria RN
Int Psychogeriatr; 2003; 15 Suppl 1():47-52. PubMed ID: 16191216
[TBL] [Abstract][Full Text] [Related]
16. Treatment of intermittent hypoxia increases phosphorylated tau in the hippocampus via biological processes common to aging.
Yagishita S; Suzuki S; Yoshikawa K; Iida K; Hirata A; Suzuki M; Takashima A; Maruyama K; Hirasawa A; Awaji T
Mol Brain; 2017 Jan; 10(1):2. PubMed ID: 28057021
[TBL] [Abstract][Full Text] [Related]
17. Alzheimer's disease is a vasocognopathy: a new term to describe its nature.
de la Torre JC
Neurol Res; 2004 Jul; 26(5):517-24. PubMed ID: 15265269
[TBL] [Abstract][Full Text] [Related]
18. Is Vasomotion in Cerebral Arteries Impaired in Alzheimer's Disease?
Di Marco LY; Farkas E; Martin C; Venneri A; Frangi AF
J Alzheimers Dis; 2015; 46(1):35-53. PubMed ID: 25720414
[TBL] [Abstract][Full Text] [Related]
19. Metabolic Syndrome and the Cellular Phase of Alzheimer's Disease.
Pugazhenthi S
Prog Mol Biol Transl Sci; 2017; 146():243-258. PubMed ID: 28253987
[TBL] [Abstract][Full Text] [Related]
20. Evidence that Alzheimer's disease is a microvascular disorder: the role of constitutive nitric oxide.
de la Torre JC; Stefano GB
Brain Res Brain Res Rev; 2000 Dec; 34(3):119-36. PubMed ID: 11113503
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
